The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and then 29 are in phase 3 which means at a small scale they've shown efficacy typically against a placebo now we want to see if there's efficacy again either versus a placebo or ideally against a current standard in a larger trial where again we're always going to continue to monitor safety but it's really this third stage that is required for fda approval
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.